[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370302-105":59,"doc-detail-370302-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clear-cell-renal-carcinoma-essentially-requires-cdkl3-for-oncogenesis","Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis","","Clear cell renal cell carcinoma (ccRCC) shows hyperactivation of HIF and mTOR signaling and has rising incidence and fatality. A spontaneous ccRCC model demonstrates that CDKL3 is indispensable for initiation and progression. CDKL3 loss does not disturb normal kidney but abrogates Akt–mTOR hyperactivity and prevents formation and growth of HIF-agitated ccRCC in vivo, supported by clinical correlations. Mechanistically, cytosolic CDKL3 acts as an adaptor enhancing mTORC2-dependent Akt activation via a phosphorylation-stabilization feedback loop that sustains oncogenic signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clear-cell-renal-carcinoma-essentially-requires-cdkl3-for-oncogenesis/370302/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clear-cell-renal-carcinoma-essentially-requires-cdkl3-for-oncogenesis/370302.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is CDKL3 considered essential for ccRCC oncogenesis?","Question",{"text":112,"@type":113},"Experiments using CDKL3 ablation show that CDKL3 is required for the initiation and progression of ccRCC, since its loss prevents formation and growth while disrupting Akt–mTOR hyperactivity in vivo.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Does removing CDKL3 affect normal kidney tissue?",{"text":117,"@type":113},"CDKL3 ablation does not affect normal kidney, but it blocks key cancer-associated signaling events and suppresses HIF-agitated ccRCC development.",{"name":119,"@type":110,"acceptedAnswer":120},"How does CDKL3 promote Akt–mTOR signaling mechanistically?",{"text":121,"@type":113},"Cytosolic CDKL3 unexpectedly functions as an adaptor that physically potentiates mTORC2-dependent Akt activation without relying on kinase activity, and mTORC2 phosphorylates and stabilizes CDKL3 to create a positive feedback loop.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370302,1790409217,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \nMEDICAL SCIENCES  \nClear cell renal carcinoma essentially requires CDKL3 foroncogenesis  \nLanjing Maa,1, Zhongqiu Panga,1, Haijiao Zhanga, Xueling Yanga, Shaoqin Zhenga, Yi Chenb, Weijie Dinga, Qing Hana, Xi Zhangc, Liu Caod , Teng Feia,  \nQiang Wange , Daming Gaof, Aina Heg,2, Ke-Bang Huh,2, Xuexin Lii,j, k, l,2, and Ren Shenga,2 Affiliations are included on p. 12.  \nEdited by Mariano Barbacid, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain; received July 29, 2024; accepted January 9, 2025  \nClear cell renal cell carcinoma (ccRCC) is the predominant human renal cancer with surging incidence and fatality lately. Hyperactivation of hypoxia-inducible factor (HIF) and mammalian target of rapamycin (mTOR) signaling are the common signatures inccRCC. Herein, we employed spontaneous ccRCC model to demonstrate the indispensabilityofan underappreciated Ser/Thr kinase, CDKL3, in the initiation and progression ofccRCC. Ablation of CDKL3 does not affect normal kidney, but abrogatesAkt-mTOR hyperactivity and thoroughly prevents the formation and growth ofthe HIF-agitated ccRCC in vivo. Remarkable clinical correlations also supported the oncogenic role of CDKL3 . Mechanism-wise, cytosolic CDKL3 unexpectedly behaves as the adaptor to physically potentiate mTORC2-dependent Akt activation without functioning through kinase activity. And mTORC2 can phosphorylate and stabilize CDKL3 to form a positive feedback loop to sustain the cancer-favored Akt-mTOR overactivation. Together, we revealed the pathological importance and molecular mechanism of CDKL3-mediated Akt-mTOR axis in ccRCC initiation and progression.  \nccRCC | CDKL3 | Akt | mTOR | oncogene  \nRenal cell carcinoma (RCC) originates from renal tubular epithelium, that consists of multiple subtypes including clear cell RCC (ccRCC), papillary RCC (pRCC), chromophobe RCC (chRCC), etc. As the most predominant form, ccRCC takes up approximately 80 to 85% of all RCCs (1). The incidence and death rate ofccRCC shows an overall increasing trend within the past years, despite that some of the incidence may rise from the cancers of unknown primary site (CUP) (2, 3) . Comprehensive genomic studies identified the major driver ofccRCC as the loss of Von Hippel–Lindau ( VHL) gene (4). VHL gene encodes the E3 ubiquitin ligase pVHL that negatively controls the protein stability of hypoxia-inducible factors (HIF1α and HIF2α) (5–7) . Despite the difference between HIF1α and HIF2α, both HIFα can dimerize with HIFβ in the absence of functional pVHL (5, 8). And together as the transcription factor, HIFα–HIFβ complex triggers the expressions of VEGF, PDGFB, TGFA, etc, leading to cell proliferation, cell metabolism, angiogenesis, and also metastasis in cancers (5) . As the top hit, the majority of all human ccRCC harbors the mutation or hypermethylation of VHL (4) . In the second place, PBRM1, which encodes the protein BAP180 (named as Baf45a in mice), has a mutation rate of 20 to 40% in ccRCC (4, 9) . Mutation of PBRM1 caused abnormal nucleosome remodeling and unbridled cell growth (10) .  \nAs the central hub of cell metabolism, Akt-mTOR signaling also plays an important role in oncogenesis (11–13). Mechanistically, growth factors stimulate the corresponding receptors to activate PI3K (Phosphoinositol-3 Kinase), which in turn leads to the T308 phosphorylation ofAkt by PDK1 (Phosphoinositide-Dependent Kinase-1) through membrane recruitment. As a sequel event, mTOR complex 2 (mTORC2) phosphorylatesAkton T450 and S473, leading to the stabilization and full activation of Akt, respectively. This event also depends on PI3K activation. Fully activated Akt can further activate mTOR complex 1 (mTORC1) through a series of phosphorylation and eventually promote cell growth and anabolism. Beyond the metabolic alterations, Akt-mTOR signaling can also stimulate the expression of HIFα. Both outcomes can essentially boost ccRCC oncogenesis. Because the hyperactivation of Akt-mTOR is a character","cbCaibWDnt77nZOK","https://ap.wps.com/l/cbCaibWDnt77nZOK","pdf",13589643,12,"English","# Abstract\n# Background: ccRCC drivers and Akt-mTOR signaling\n# Findings: CDKL3 requirement in initiation and progression\n# Mechanism: CDKL3 as an adaptor in mTORC2-Akt activation\n# Significance\n# Author contributions","[{\"question\":\"Why is CDKL3 considered essential for ccRCC oncogenesis?\",\"answer\":\"Experiments using CDKL3 ablation show that CDKL3 is required for the initiation and progression of ccRCC, since its loss prevents formation and growth while disrupting Akt–mTOR hyperactivity in vivo.\"},{\"question\":\"Does removing CDKL3 affect normal kidney tissue?\",\"answer\":\"CDKL3 ablation does not affect normal kidney, but it blocks key cancer-associated signaling events and suppresses HIF-agitated ccRCC development.\"},{\"question\":\"How does CDKL3 promote Akt–mTOR signaling mechanistically?\",\"answer\":\"Cytosolic CDKL3 unexpectedly functions as an adaptor that physically potentiates mTORC2-dependent Akt activation without relying on kinase activity, and mTORC2 phosphorylates and stabilizes CDKL3 to create a positive feedback loop.\"}]","Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis | PDF",1790187879,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6ccb04293e730790e483ae5c109e070.webp",983,1316,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4dc5b48e984bd9faf3bb6cbd59beecf.webp",982,1315,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d5d4381322d444a3b0e192c5f2866d1.webp",981,1313,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/161094a0bfe8a3fcc28cff57ee5cbdda.webp",980,1312]